Union Bancaire Privee UBP SA Has $574,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Union Bancaire Privee UBP SA reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 52.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,676 shares of the company's stock after selling 1,829 shares during the quarter. Union Bancaire Privee UBP SA's holdings in HCA Healthcare were worth $574,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Congress Wealth Management LLC DE grew its position in HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after buying an additional 34 shares in the last quarter. Evergreen Private Wealth LLC grew its position in HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares in the last quarter. Whittier Trust Co. grew its position in HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after buying an additional 41 shares in the last quarter. Barden Capital Management Inc. grew its position in HCA Healthcare by 1.4% during the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after buying an additional 41 shares in the last quarter. Finally, Coldstream Capital Management Inc. grew its position in HCA Healthcare by 1.3% during the fourth quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock worth $1,042,000 after buying an additional 44 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Trading Down 0.2%

Shares of HCA traded down $0.91 during trading hours on Friday, reaching $370.76. The stock had a trading volume of 872,296 shares, compared to its average volume of 1,452,711. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm has a 50-day moving average of $358.43 and a 200 day moving average of $333.18. The company has a market cap of $89.20 billion, a P/E ratio of 16.88, a P/E/G ratio of 1.10 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter in the prior year, the company earned $5.36 EPS. The firm's quarterly revenue was up 5.7% on a year-over-year basis. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of analyst reports. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $392.47.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.